Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05252429 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05252429
- Sponsor
- Hokkaido University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-06
- Primary completion
- 2025-05-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.